Intercontinental Mark Hopkins • San Francisco

Thanks to all of our speakers, sponsors and attendees for making the first PharmAsia Summit a tremendous success!

Registration	Registration 3 or More	Hotel Information	2009 Agenda
	Sponsorship	Brochure

Best Practices and Case Studies for Growing your R&D Pipeline through Financing, M&A and Strategic Partnership

Featuring THE Most Senior Level Business Development, R & D and Regulatory Strategists in the Industry, including:

Tony Zhang Managing Director and Site Head Eli Lilly Global R&D, China	Li Chen Chief Scientific Officer Roche R&D Center (China) Ltd.	Robert Armstrong VP, Global External Research and Development Eli Lilly and Company	Andrew von Eschenbach Former FDA Commissioner	G.V. Prasad Vice Chairman and CEO Dr. Reddy’s Laboratories

The ONLY U.S. event where you can have face-to-face dialogue with THE key players from China and India.

Hear case studies on:

• The impact of China’s health care reform
• New models in R&D, partnering and commercial models – DIRECTLY from major players who are actually implementing them!
• U.S. FDA’s strategy in Asia
• China health care reform – THE elephant in the room.

Hear all this in the U.S. – you don’t have to blow your travel budget flying to China and India. Asia leaders are coming here!

From Discovery to Clinical Trials to Market

As pharma looks to broaden its capabilities beyond its four walls and spread the risk and rewards of drug development, companies are looking east to the multi-billion dollar Asian market, especially emerging markets like China and India. Already many biopharma companies are taking advantage of Asia’s scientific talent pool and large patient base to outsource R&D and clinical trials, and to develop unique alliances with local companies and universities to speed up drug development. With the global economic crisis upon us, and major pharma industry challenges like the approaching patent cliff, these R&D trends are likely to accelerate in coming years.

But speeding up development is just one reason multinationals want to build a presence in Asia. The other reason: emerging markets like China and India are the fastest growing markets for pharmaceuticals, with some experts forecasting growth of 14-15 percent in 2009, compared to 1-2 percent growth in the U.S. Yet regulatory, reimbursement and commercial challenges in these markets are considerable, and major changes are on the horizon, including China health care reform and the move toward a central India regulatory authority modeled after U.S. FDA.

	In light of these tremendous opportunities and challenges, Windhover conferences, sponsors of the blockbuster Pharmaceutical Strategic Alliances (PSA), and PharmAsia News – which leverages the editorial excellence of “The Pink Sheet” to provide
regulatory, legal and financial analysis of developments in China, India and The Pacific Rim – will gather the industry’s most senior leaders focusing on Asia and emerging markets to share best practice case studies; successful regulatory, reimbursement and commercial strategies; and strategic partnerships from discovery to clinical trials.

PharmAsia Summit is THE most strategic level meeting where senior level biotech and pharma executives share real-life case studies on how they are building a presence in Asia – from drug development to market. PharmAsia Summit will gather the industry’s most senior leaders to share best practice case studies, successful business models and strategic partnerships from discovery to clinical trials.

Join us for three days of interactive discussions, case studies and panels, and capitalize on Asia’s booming pharmaceutical market.

BEYOND THE BASICS! PharmAsia Summit is the only event featuring marquee level speakers and topics by the powerhouse editorial team from IN VIVO, START-UP, "THE PINK SHEET" and PHARMASIA NEWS. Discussions include:

• Heads of China R & D Roundtable: A Look at Different Models for Approaching Innovation in China
• China’s Changing Regulatory Landscape: The future of Chinese Healthcare Reform and What it Means for both Multinational and Chinese Companies
• Regulators Up Close: What can We Expect from Market Regulators in Asia?
• Indian Perspective on Globalization
• Partnering For Success In Emerging Markets: How Strategic Partnerships and M & A have Changed the Face of R & D in Asia
• Investment Outlook For Asia: VC Perspectives on their Best Bets
• Tips for Success: Working and Partnering with a CRO in Asia
• Building a Sales and Commercial Presence in China: How Do You Maximize Market Opportunities?
• Overcoming Intellectual Property Issues in Asia
• How to Conduct U.S. FDA Inspections in China

Meet the Most Senior Level Speakers in the Business, including:

Tony Zhang Managing Director and Site Head Eli Lilly Global R&D, China Samantha Du CEO Hutchison Pharma Ge Li CEO WuXi Apptec Andrew von Eschenbach Former FDA Commissioner Alex Wu CEO Crown Bio G.V. Prasad Vice Chairman and CEO Dr. Reddy’s Laboratories Song Ruilin Executive Director-General Research Center for Medicinal Policy Chinese Pharmaceutical Association

Kiran Marthak CEO Veeda Robert Armstrong VP, Global External Research and Development Eli Lilly and Company Jonathon Wang Senior Managing Director, Asia OrbiMed Advisors Zhu Shen CEO BioForesight Yael Weiss, MD, PhD Director, Licensing And External Research Merck Research Laboratories Li Chen Chief Scientific Officer Roche R&D Center (China) Ltd.

Here’s Just a Sample of Companies that are sending their Teams. Don’t be Left Behind!

Adjuvant Global Advisors, LLC Association of Biotechnology Led Enterprises (ABLE) 3S Bio, Inc. BayBio BayHelix Bio Foresight BioMarin Pharmaceutical BioPharma Today Burrill & Company Chinese-American BioPharmaceutical Society (CABS) Charles River Laboratories ChemPartner California Healthcare Institute Chinese Pharmaceutical Association Crown Bioscience CurrentPartnering Daylight Forensic & Advisory Dr. Reddy's Laboratories DSM Pharmaceutical Products Eli Lilly Global R&D, China Eli Lilly and Company Elsevier Business Intelligence EuroPharma Today US Food & Drug Administration (FDA) FDA CHINA Genentech Genomic Health Inc. Glaxosmithkline Greenleaf Health Llc Hutchison Medipharma Ltd. IN VIVO Johnson & Johnson Jubilant Biosys Jubilant Organosys Limited

LEAD Therapeutics Licensing Executives Society Lilly Singapore Centre for Drug Discover Merck & Co. Inc. Merck Research Laboratories Nishith Desai Associates OrbiMed Advisors Parexel PharmAsia News PharmaConnections Pharmalicensing.com Pfizer Pfizer China Piramal Life Sciences Procter & Gamble Pharmaceuticals Quintiles Roche Roche R & D Center Sanofi-Aventis Simcere Pharmaceutical Group Sino-American Biomedical and Pharmaceutical Association START-UP Susquehanna Financial Group Takeda Pharm Am Takeda Pharmaceuticals The Gold Sheet The Pink Sheet The Pink Sheet Daily Transcept Pharmaceuticals India Chamber of Commerce-USAIC Veeda Vertex Pharmaceuticals Wu Xi Apptec

Sponsorship Opportunities Available –Access the Most Senior-Level Decision-Makers at PharmAsia Summit

Why Attend PharmAsia Summit?

• Capitalize on potential new business and collaboration opportunities with the hottest Asian partners
• Network with hundreds of potential pharmaceutical and biotech partners through 1:1 meetings, cocktail parties, luncheons and refreshment breaks
• Hear about exciting new trends in Asian life sciences and dealmaking strategies
• Meet new partners and clients looking to expand capabilities in Asia
• Benchmark your Asia strategy against what your competitors are doing and why
• Maximize your strategic alliance opportunities by hearing CEOs, senior R&D and senior business development executives who share lessons learned, practical advice and strategies on how to build your R&D pipeline - both internally and externally
• Find out how to commercialize your product, valuate your alliances and develop a reimbursement strategy in Asia
• Hear expert panels about drug development in Asia — viewpoints from the top investigators in the field
• Hear only from handpicked sessions, by FDC/Windhover’s #1 editorial department (PharmAsia News, ”The Pink Sheet,” IN VIVO and Start-Up)
• Hone your dealmaking skills at our compelling plenary & keynote sessions from industry thought leaders on new trends and dealmaking strategies
• Find key new financing sources to fuel your growth
• Showcase your company’s products and services in front of the most active dealmakers — who are actively seeking you

Why sponsor PharmAsia Summit?

Windhover and PharmAsia News are making available a limited number of sponsorships in conjunction with this event, ensuring great visibility among a select number of companies. Here are just some of the reasons you should consider a PharmAsia Summit Sponsorship:

• China, India and emerging markets in Asia are the hottest regions for R&D and commercial growth for big pharma. PharmAsia Summit will attract senior-level executives in R&D, government & legal affairs, and business development & licensing from major pharmaceutical and biotechnology companies growing their business in this region. Associating your firm as a sponsor of the event ensures that key decision-makers recognize your brand as a leader in the region.
• PharmAsia Summit will attract some of the most notable names in the industry to speak candidly of the opportunities and challenges in China, India and emerging markets for biopharma. This assures that your brand is associated with an informative event that delivers real value to its attendees.
• PharmAsia Summit will attract senior executives from throughout the biotech and pharmaceutical industries, creating a rich dynamic of key decision-makers comparing notes on strategic issues that will impact everyone in the room. As a sponsor to this event, you will be regarded as a co-host to our intellectual gathering, reaping the benefits of high visibility and recognition as an industry thought leader

PLUS!

• Stand out from the crowd: Elevate your status as one of the major players in the Asia space
• Showcase your intellectual expertise in front of the most senior level executives in the health care industry looking to expand into Asia
• Meet key prospects and demonstrate your capabilities
• Raise the profile of your company’s image, products, services and partnering abilities
• Take advantage of Windhover’s powerful direct marketing strategies: Send your message to tens of thousands of your target executives
• Strengthen your position as a market leader among C-level and senior-level decision-makers
• Receive multiple passes to attend our conferences. Since many of your co-workers will be attending anyway, sponsorships are a cost-effective way to maximize passes to the event while getting additional exposure

Sponsoring PharmAsia Summit provides unparalleled access to key decision-makers and today’s leading executives. Connect your organization to the most respected and knowledgeable health care information provider by sponsoring.

	Sponsors
- Host Sponsor - - Workshop Sponsors - - Regional Supporting Organizations - - Regional Partner - - Association Sponsors - - Major Supporting Publications - - Media Sponsors -